These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8384233)

  • 1. Physical interaction between Langerhans cells and T-lymphocytes during antigen presentation in vitro.
    Concha M; Vidal A; Garcés G; Figueroa CD; Caorsi I
    J Invest Dermatol; 1993 Apr; 100(4):429-34. PubMed ID: 8384233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural characteristics of the contact zones between Langerhans cells and lymphocytes.
    Concha M; Figueroa CD; Caorsi I
    J Pathol; 1988 Sep; 156(1):29-36. PubMed ID: 3193298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction of class II MHC+ Langerhans cell-like interstitial dendritic antigen-presenting cells in murine dermis from dermal macrophages.
    Duraiswamy N; Tse Y; Hammerberg C; Kang S; Cooper KD
    J Invest Dermatol; 1994 Nov; 103(5):678-83. PubMed ID: 7963656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
    Grabbe S; Bruvers S; Granstein RD
    J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.
    Schuler G; Steinman RM
    J Exp Med; 1985 Mar; 161(3):526-46. PubMed ID: 3871837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells.
    Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J
    Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells.
    Gerberick GF; Ryan CA; Von Bargen EC; Stuard SB; Ridder GM
    J Invest Dermatol; 1991 Aug; 97(2):210-8. PubMed ID: 1649226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
    Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
    J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective enrichment of murine epidermal Langerhans cells by a modified(mismatched) panning technique.
    Koch F; Kämpgen E; Schuler G; Romani N
    J Invest Dermatol; 1992 Dec; 99(6):803-7. PubMed ID: 1469295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A inhibits accessory cell and antigen-presenting cell functions of epidermal Langerhans cells.
    Furue M; Katz SI
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):87-91. PubMed ID: 3259044
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of Langerhans cells in antigen presentation.
    Katz SI; Cooper KD; Iijima M; Tsuchida T
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):96s-98s. PubMed ID: 3874249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophils, differentiated macrophages, and monocyte/macrophage antigen presenting cells infiltrate murine epidermis after UV injury.
    Cooper KD; Duraiswamy N; Hammerberg C; Allen E; Kimbrough-Green C; Dillon W; Thomas D
    J Invest Dermatol; 1993 Aug; 101(2):155-63. PubMed ID: 8393901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
    Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
    J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines.
    Tokura Y; Yagi J; O'Malley M; Lewis JM; Takigawa M; Edelson RL; Tigelaar RE
    J Invest Dermatol; 1994 Jan; 102(1):31-8. PubMed ID: 8288908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory cell-T lymphocyte interactions. Antigen-dependent and -independent clustering.
    Inaba K; Steinman RM
    J Exp Med; 1986 Feb; 163(2):247-61. PubMed ID: 2935590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose ultraviolet B-irradiated Langerhans cells preferentially activate CD4+ cells of the T helper 2 subset.
    Simon JC; Cruz PD; Bergstresser PR; Tigelaar RE
    J Immunol; 1990 Oct; 145(7):2087-91. PubMed ID: 1975824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain.
    Puré E; Inaba K; Crowley MT; Tardelli L; Witmer-Pack MD; Ruberti G; Fathman G; Steinman RM
    J Exp Med; 1990 Nov; 172(5):1459-69. PubMed ID: 2121888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Langerhans cell.
    Thiers BH
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 1):519-22. PubMed ID: 6176601
    [No Abstract]   [Full Text] [Related]  

  • 20. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes.
    Ronchese F; Hausmann B
    J Exp Med; 1993 Mar; 177(3):679-90. PubMed ID: 8436906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.